Participants 79 120 4
men receiving therapy for prostate cancer
Participants 611 671 4
men receiving androgen deprivation for their prostate cancer
Participants 1208 1341 7
195 men (65 subjects per arm) undergoing treatment for prostate cancer involving ADT in the cities of Perth and Brisbane in Australia
